| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1130 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 931 | 2020 |
| Distinct early serological signatures track with SARS-CoV-2 survival C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke, C Loos, DJ McCulloch, ... Immunity 53 (3), 524-532. e4, 2020 | 366 | 2020 |
| Compromised humoral functional evolution tracks with SARS-CoV-2 mortality T Zohar, C Loos, S Fischinger, C Atyeo, C Wang, MD Slein, J Burke, J Yu, ... Cell 183 (6), 1508-1519. e12, 2020 | 293 | 2020 |
| Compromised SARS-CoV-2-specific placental antibody transfer C Atyeo, KM Pullen, EA Bordt, S Fischinger, J Burke, A Michell, MD Slein, ... Cell 184 (3), 628-642. e10, 2021 | 198 | 2021 |
| A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis CB Karsten, N Mehta, SA Shin, TJ Diefenbach, MD Slein, W Karpinski, ... Journal of immunological methods 471, 46-56, 2019 | 143 | 2019 |
| Mapping functional humoral correlates of protection against malaria challenge following RTS, S/AS01 vaccination TJ Suscovich, JK Fallon, J Das, AR Demas, J Crain, CH Linde, A Michell, ... Science translational medicine 12 (553), eabb4757, 2020 | 103 | 2020 |
| Discrete SARS-CoV-2 antibody titers track with functional humoral stability YC Bartsch, S Fischinger, SM Siddiqui, Z Chen, J Yu, M Gebre, C Atyeo, ... Nature communications 12 (1), 1018, 2021 | 88 | 2021 |
| SARS-CoV-2-specific ELISA development V Roy, S Fischinger, C Atyeo, M Slein, C Loos, A Balazs, C Luedemann, ... Journal of immunological methods 484, 112832, 2020 | 88 | 2020 |
| A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus BM Gunn, R Lu, MD Slein, PA Ilinykh, K Huang, C Atyeo, SL Schendel, ... Immunity 54 (4), 815-828. e5, 2021 | 45 | 2021 |
| Evolution of early SARS-CoV-2 and cross-coronavirus immunity C Loos, C Atyeo, S Fischinger, J Burke, MD Slein, H Streeck, ... MSphere 5 (5), 10.1128/msphere. 00622-20, 2020 | 41 | 2020 |
| Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022 C Atyeo, MD Slein, S Fischinger, J Burke, A Schäfer, SR Leist, ... JCI insight 6 (1), 2021 | 38 | 2021 |
| Epidemiological and immunological features of obesity and SARS-CoV-2 EJ Nilles, SM Siddiqui, S Fischinger, YC Bartsch, M de St. Aubin, G Zhou, ... Viruses 13 (11), 2235, 2021 | 20 | 2021 |
| Coupling of single molecule, long read sequencing with IMGT/HighV-QUEST analysis expedites identification of SIV gp140-specific antibodies from scFv phage display libraries SY Han, A Antoine, D Howard, B Chang, WS Chang, M Slein, G Deikus, ... Frontiers in Immunology 9, 329, 2018 | 16 | 2018 |
| Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity IM Backes, BK Byrd, MD Slein, CD Patel, SA Taylor, CR Garland, ... Journal of Experimental Medicine 219 (12), e20220110, 2022 | 13 | 2022 |
| Evolution of functional antibodies following acute Epstein-Barr virus infection CB Karsten, YC Bartsch, SA Shin, MD Slein, HM Heller, K Kolandaivelu, ... PLoS pathogens 18 (9), e1010738, 2022 | 7 | 2022 |
| Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D MD Slein, IM Backes, CR Garland, NS Kelkar, DA Leib, ME Ackerman Cell Reports Medicine 5 (2), 2024 | 1 | 2024 |
| Reviewed by: The simian immunodeficiency virus (SIV)/macaque model of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome pathogenesis is critical for … ML Smith, IBF Fofana, SY Han, A Antoine, D Howard, B Chang, ... Next-Generation Sequencing of Human Antibody Repertoires for Exploring B …, 2020 | | 2020 |
